University of Twente   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Enschede Netherlands (1961)

Organization Overview

First Clinical Trial
2003
NCT00405925
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Medisch Spectrum Twente and University of Twente | Rijnstate | Rijnstate Hospital and University of Twente | Rijnstate Hospital, Arnhem, the Netherlands | Rijnstate Hospital, Arnhem, The Netherlands | University of Twente | Ziekenhuisgroep Twente | ZiekenhuisGroup Twente

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Delirium (Phase 2)

Depression (Phase 2)

Epilepsy (Phase 2)

HIV Infections (Phase 3)

Hyperinsulinism (Phase 2)

Hypogonadism (Phase 3)

Peripheral Arterial Disease (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 8
  • # of Trial APIs: 17